2,400
Participants
Start Date
June 30, 2014
Primary Completion Date
February 28, 2019
Study Completion Date
February 28, 2019
Telephone Reminder
Nurse will provide telephone contact to patients every 3 month to remind them to adhere to treatment, provide support and empower them to discuss with their doctors about their treatment needs and any concerns
Doctor-Nurse Follow Up
Patient will be followed by a doctor-nurse team at least 3 monthly to achieve multiple targets recommended as A1c\<7%, BP\<130/80 mmHg, LDL-C\<1.8 mmol/l, triglyceride\<1.7 mmol/l and persistence with RAS inhibitors taking into consideration safety and tolerability (e.g. hypoglycemia, hypotension, changes in electrolytes). Patient report will be given after follow up.
Personalized Risk Report for Patient Empowerment
Patients will be given with personalized risk reports after baseline and 12-month repeat comprehensive assessments.
Theptarin Hospital, Bangkok
The Forth Affiliated Hospital of China Medical University, Shengyang
Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong
Department of Medicine, Alice Ho Miu Ling Nethersole Hospital, Hong Kong
Universiti Sains Malysia, Kubang Kerian
University Malaya Medical Centre, University of Malaya, Kuala Lumpur
Bucheon St. Mary's Hospital, The Catholic University of Korea, Seoul
Hally University Dongtan Sacred Heart Hospital, Gyeonggi-do
Taipei Veterans General Hospital, Taipei
Hoa Hao MEDIC Company LMT, Ho Chi Minh City
Seoul St.Mary's Hospital, The Catholic Unviersity of Korea, Seoul
Asia Diabetes Foundation
OTHER